France · 
Who invested in Corteria Pharmaceuticals?
Corteria Pharmaceuticals's investors include OrbiMed, Omnes and KurmaPartners.
France · Series A startup
Who invested in Corteria Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $70MSept 2023
- Investors
- 3
The rounds
- Sept 2023
Founders and team
From Corteria Pharmaceuticals's own website: 1 on the team.
- Philip JaniakCEO
AdvisersMark Kowala
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Corteria Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Corteria Pharmaceuticals
How much has Corteria Pharmaceuticals raised?
Corteria Pharmaceuticals has raised $70M across 1 round since 2023.
When did Corteria Pharmaceuticals last raise?
Corteria Pharmaceuticals's most recent round was a Series A of $70M in Sept 2023.
What was Corteria Pharmaceuticals's biggest round?
Its most recent round, $70M in Sept 2023, is also its largest on record.
Who backed Corteria Pharmaceuticals first?
Corteria Pharmaceuticals's first round on record, in Sept 2023, was backed by OrbiMed, Omnes and KurmaPartners.
What stage is Corteria Pharmaceuticals at?
Corteria Pharmaceuticals's latest named round is a Series A, in Sept 2023.
Where is Corteria Pharmaceuticals based?
Corteria Pharmaceuticals is based in France.
Companies like Corteria Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.